Corrections
Corrections
The February 2005 article, "Hormonal-based male contraceptive moves ahead," p. 20, contained inaccurate information on an upcoming male contraception study.
According to Diana Blithe, PhD, program director of the Contraceptive Clinical Trials Network at the National Institute of Child Health and Human Development (NICHD) within the National Institutes of Health, the study is being conducted by the NICHD at two clinical sites: one headed by Christina Wang, MD, at Harbor-UCLA Medical Center in Torrance, CA, and the other headed by William Bremner, MD, PhD, at the University of Washington in Seattle. Scientists will be testing a combination of testosterone gel and Nestorone gel. The Nestorone gel will be prepared and supplied by the Population Council, a New York City-based research organization.
The May 2005 article, "Bacterial vaginosis is focus of new research," p. 58, contained an error in the dosing regimen for metronidazole gel. The correct regimen is once a day for five days.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.